Analyzing Oak Street Health (NYSE:OSH) & Reunion Neuroscience (NASDAQ:REUN)

Oak Street Health (NYSE:OSHGet Rating) and Reunion Neuroscience (NASDAQ:REUNGet Rating) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, earnings, dividends, analyst recommendations, institutional ownership, risk and valuation.

Profitability

This table compares Oak Street Health and Reunion Neuroscience’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Oak Street Health -27.11% -1,883.59% -25.98%
Reunion Neuroscience -1,125.12% -65.19% -45.08%

Analyst Recommendations

This is a breakdown of current ratings and price targets for Oak Street Health and Reunion Neuroscience, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Oak Street Health 1 6 6 0 2.38
Reunion Neuroscience 0 0 0 0 N/A

Oak Street Health currently has a consensus price target of $31.47, suggesting a potential upside of 50.77%. Given Oak Street Health’s higher probable upside, equities analysts clearly believe Oak Street Health is more favorable than Reunion Neuroscience.

Risk & Volatility

Oak Street Health has a beta of 2.32, meaning that its stock price is 132% more volatile than the S&P 500. Comparatively, Reunion Neuroscience has a beta of 1.39, meaning that its stock price is 39% more volatile than the S&P 500.

Earnings and Valuation

This table compares Oak Street Health and Reunion Neuroscience’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Oak Street Health $1.43 billion 3.52 -$409.40 million ($2.27) -9.19
Reunion Neuroscience $3.88 million 4.47 -$43.63 million ($3.85) -0.39

Reunion Neuroscience has lower revenue, but higher earnings than Oak Street Health. Oak Street Health is trading at a lower price-to-earnings ratio than Reunion Neuroscience, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

91.3% of Oak Street Health shares are held by institutional investors. Comparatively, 71.4% of Reunion Neuroscience shares are held by institutional investors. 11.4% of Oak Street Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Oak Street Health beats Reunion Neuroscience on 9 of the 13 factors compared between the two stocks.

About Oak Street Health

(Get Rating)

Oak Street Health, Inc., together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2021, it operated 129 centers in 19 states, including Illinois, Michigan, Pennsylvania, Ohio, and Texas. The company was founded in 2012 and is headquartered in Chicago, Illinois.

About Reunion Neuroscience

(Get Rating)

Field Trip Health Ltd. engages in the development and delivery of psychedelic- assisted therapies in North America. The company operates Field Trip Health Centres that provide psychedelic therapies; offers Field Trip Digital apps; operates Field Trip Discovery, a drug development division that develops the next generation of psychedelic molecules; and provides ketamine-assisted therapy for the treatment of depression, anxiety, addiction, and other conditions. Field Trip Health Ltd. was founded in 2008 and is headquartered in Toronto, Canada.

Receive News & Ratings for Oak Street Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oak Street Health and related companies with MarketBeat.com's FREE daily email newsletter.